ÜBER DIESEN PODCAST 🔗
A narrative podcast series hosted by journalist Surani Fernando that goes beyond the headlines to explore how biotech companies are really built — from bold ideas and impressive fundraises to the science that could reshape healthcare. Surani speaks with founders, CEOs, investors, and experts to uncover origin stories, company missions, and the challenges of bringing ambitious discoveries to market. Through thoughtful, independent reporting, Raising Biotech examines what it really takes to turn breakthroughs into lasting impact for patients and the industry.
For guest or sponsor pitches, please get in touch with Surani Fernando on LinkedIn or email raisingbiotech@gmail.com.
For guest or sponsor pitches, please get in touch with Surani Fernando on LinkedIn or email raisingbiotech@gmail.com.
Hosts:
Aktualisierungshäufigkeit:
monthly
Durchschnittliche Audiolänge:
30 minutes
Gastinterviews
Englisch
Vereinigte Staaten
28 Folgen
seit 13. November 2023
episodic
NEUESTE FOLGEN 🔗
In this episode, Surani explores the unconventional start-up story of Infinimmune, an antibody discovery company founded in 2022 by five former 10x Genomics scientists. Starting with a scientific hunch that advances in single-cell sequencing were revealing previously overlooked antibody biology, t…
VERGANGENE FOLGEN SUCHEN
Vorhandene Folgen von Raising Biotech durchsuchen.
FRÜHERE EPISODEN 🔗
In this July summer episode, we slow things down again and revisit a conversation from the Raising Biotech archive.
Today's episode is a replay from November 2023, featuring Synchron, a company developing implantable brain-computer interfaces (BCIs) to restore communication and digital independenc…
In this special Investor Spotlight edition of Raising Biotech, Surani sits down with Dr. Jakob Dupont, Executive Partner at Sofinnova Investments, to explore one of the most unusual career trajectories in biotech. Before becoming a venture investor, Dupont spent decades as a physician, cancer resea…
In this episode, Surani explores one of biotech’s most controversial and ambitious frontiers: psychedelic medicine.
At the center of the story is Compass Pathways, the London-based biotech attempting to bring synthetic psilocybin through the modern drug approval system for treatment-resistant dep…
In this episode, Surani takes a deep dive with experts into biotechs hottest new hype cycle -- GLP-1s. Over the past couple years, biotech investing has felt like it’s entering a new gravitational field, with GLP-1s at the center. Once a niche diabetes therapy, these drugs have evolved into a comme…
In this episode, Surani speaks with George Magrath, CEO of Opus Genetics, about the realities of leading a public biotech company through a major strategic pivot and intense market scrutiny. Opus Genetics emerged from a 2024 reverse merger between Nasdaq-listed Ocuphire Pharma and a private gene th…
In this episode, we focus on the personal journey of Sheila Gujrathi, a physician turned biotech builder whose career spans medicine, big pharma, rapid IPOs, and billion dollar exits. We explore what it takes to raise biotech across cycles, from early clinical development to public markets, and how…
In this early-January episode, we slow things down, and reflect...
Today’s episode is a replay from the Raising Biotech archive — a conversation originally recorded in November 2023 with eGenesis, a company working at the frontier of xenotransplantation, or transplanting genetically modified a…
In this episode, we dive into one of the most universal aesthetic concerns on the planet: pattern hair loss. Despite affecting more than 80 million people in the US and over a billion globally, innovations in treatment have barely moved in decades. Veradermics is aiming to change that with an exten…
In this special on-the-ground episode of Raising Biotech, Surani takes you inside BIO-Europe 2025 in Vienna — the dealmaking, the caffeine, and the cautious optimism shaping Europe’s biotech landscape right now.
Over three packed days, 6,000+ attendees from more than 60 countries gathered to brok…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Surani Fernando, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.
PODCAST-SUCHMASCHINE
Auf unserer Website können Sie3,821,555-Podcasts und195,372,593-Folgen nach Personen, Orten oder Themen durchsuchen.
Eine Investition in Wissen bringt die besten Zinsen – deshalb höre ich Podcasts.
‐ Benjamin "Llamacorn" Franklin
VERGANGENE FOLGEN SUCHEN
Vorhandene Folgen von Raising Biotech durchsuchen.
PODCAST WIRD BEANSPRUCHT
This podcast page is claimed and managed by
@surani
BEARBEITEN
Vielen Dank, dass Sie uns helfen, die Podcast-Datenbank auf dem neuesten Stand zu halten.
